Principle investigator

Prof. Dr. med. Oliver Kurzai

Prof. Dr. med. Oliver Kurzai


Phone: +49 3641 532-1347


Curriculum vitae
Since 2021 Head of Institute for Hygiene and Microbiology, Julius Maximilians University Würzburg
Since 2017 Chair of Medical Microbiology and Mycology, Institute for Hygiene and Microbiology, Julius Maximilians University Würzburg
Since 2017 Head of the research group Fungal Septomics at Leibniz Institute for Natural Product Research and Infection Biology – Hans-Knöll-Institute Jena
2009-2016 Professor for Fungal Septomics, Friedrich Schiller University Jena
2008 Habilitation in medical microbiology, Julius Maximilians University Würzburg
2006 Medical specialist in microbiology, virology and infection epidemiology (Bayerische Landesärztekammer)
2002 Dr. med. (summa cum laude), Julius Maximilians University Würzburg
2001-2008 Institute for Hygiene and Microbiology, Julius-Maximilians-Universität Würzburg


Awards · appointments · scientific activities
Since 2018 Member and Vice Speaker, Executive Board, Center for Infectious Diseases Research, Würzburg, Germany
Since 2015 National Delegate, Antifungal Susceptibility Testing Subcommittee, EUCAST
Since 2014 Head of the National Reference Center for Invasive Fungal Infections (NRZMyk)
Since 2012 Scientific Manager of the consortium “InfectControl 2020 – New Antiinfection Strategies – Science · Society · Economy” within the BMBF-Programme “Zwanzig 20 – Partnership for Innovation” (Head: Prof. A. Brakhage)
Since 2012 Editor-in-Chief, Medical Mycology Case Reports, Mitglied (ex officio) of the executive board of the International Society for Human & Animal Mycology (ISHAM)
Since 2011 Elected note taker at the Deutschsprachige Mykologische Gesellschaft DMykG
2015-2016 Speaker of ZIK Septomics
2013-2015 Board member of the Integrated Research and Treatment Center “Center for Sepsis Control and Care” (CSCC) at University Hospital Jena
2009 Hans-Rieth-poster prize from the Deutschsprachige Mykologische Gesellschaft (DMykG)
2008 Award from the Deutsche Gesellschaft für Hygiene und Mikrobiologie


Selected publications
  • Häder A et al. (2023) Pathogen-specific innate immune response patterns are distinctly affected by genetic diversity. Nat Commun 14(1): 3239.
  • Mirhakkak MH et al. (2023) Genome-scale metabolic modeling of Aspergillus fumigatus strains reveals growth dependencies on the lung microbiome. Nat Commun 14(1): 4369.
  • Seif M et al. (2022) CAR T cells targeting Aspergillus fumigatus are effective at treating invasive pulmonary aspergillosis in preclinical models. Sci Transl Med 14(664): eabh1209.
  • Bloos F et al. (2022) (1 → 3)-β-D-Glucan-guided antifungal therapy in adults with sepsis: the CandiSep randomized clinical trial. Intensive Care Med 48(7): 865-875.
  • Barber AE et al. (2021) Aspergillus fumigatus pan-genome analysis identifies genetic variants associated with human infection. Nat Microbiol 6(12): 1526-1536.